Airway augmentation and maintenance through laryngeal chemodenervation in children with impaired vocal fold mobility.
Smith
Marshall E
ME
Division of Otolaryngology/Head and Neck Surgery, 3C-120 SOM, University of Utah School of Medicine, 50 N Medical Dr, Salt Lake City, UT 84132, USA. marshall.smith@hsc.utah.edu
Park
Albert H
AH
Muntz
Harlan R
HR
Gray
Steven D
SD
D000293:Adolescent; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007818:Laryngeal Diseases / Q000188:drug therapy; D007830:Larynx / Q000187:drug effects*; D008297:Male; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D012123:Pulmonary Ventilation / Q000187:drug effects; D012008:Recurrence; D012120:Respiration Disorders / Q000188:drug therapy; D012135:Respiratory Sounds / Q000187:drug effects; D014140:Tracheotomy; D014826:Vocal Cord Paralysis / Q000188:drug therapy*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A